ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.
Clinical trial NCT07390409 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07390409
- Sponsor
- Desmond Tutu HIV Foundation
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-29
- Primary completion
- 2028-03-01
- Enrollment
- 3700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.